PHG
Koninklijke Philips N.V.
NYSE · Healthcare · Medical - Devices · NL
$25.89
−0.61%Year over year
Reported trailing growth
- Revenue
- -1.1%
- EBITDA
- +49.3%
- EBIT
- +57.9%
- EPS
- +582.4%
- Free cash flow
- +334.4%
- Operating cash flow
- +484.1%
Forward estimates
Based on analyst estimates
- Revenue
- -2.1%
- EBITDA
- +30.9%
- EPS
- +41.1%
Three-year CAGR
- Revenue
- +0.0%
- EBITDA
- +184.2%
- EBIT
- +169.2%
- Net income
- +227.5%
- EPS
- +226.7%
- Free cash flow
- -32.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026